Keros Therapeutics Inc

Keros Therapeutics Inc

KROS

Market Cap$594.96M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Keros Therapeutics IncKeros Therapeutics Inc-3.2--32%--
$13.90

Current Fair Value

0.9% downside

Overvalued by 0.9% based on the discounted cash flow analysis.

Share Statistics

Market cap$594.96 Million
Enterprise Value$53.89 Million
Dividend Yield$0 (0%)
Earnings per Share$-5
Beta1.39
Outstanding Shares40,337,720

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-3.15
PEG-9.2
Price to Sales-
Price to Book Ratio1.0
Enterprise Value to Revenue82.78
Enterprise Value to EBIT-0.27
Enterprise Value to Net Income-1
Total Debt to Enterprise0.35
Debt to Equity0.03

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Keros Therapeutics Inc